Protein S Thr103Asn mutation associated with type II deficiency reproduced in vitro and functionally characterised

Thrombosis and Haemostasis

Volumn 84, Issue 3, 2000, Pages 413-419

  Giri, T K ^a   De Frutos, P G ^a   Dahlback, B ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Anticoagulant protein S; Functional deficiency; In vitro reproduction; Natural mutation

Indexed keywords

BLOOD CLOTTING FACTOR 5A; BLOOD CLOTTING FACTOR 8A; PROTEIN C; PROTEIN S;

ANTICOAGULATION; ARTICLE; DISEASE ASSOCIATION; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PURIFICATION; PROTEIN S DEFICIENCY;

EID: 0033824233     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1614037     Document Type: Article

References (42)

1. The protein C anticoagulant system: Inherited defects as basis for venous thrombosis
2. Neonatal purpura fulminans associated with homozygous protein S deficiency
3. Familial protein S deficiency is associated with recurrent thrombosis
4. Plasma protein S deficiency in familial thrombotic disease
5. Protein C and protein S deficiencies
6. Effects of protein S and factor Xa on peptide bond cleavages during inactivation of factor Va and factor VaR506Q by activated protein C
7. The mechanism of inactivation of human factor V and human factor Va by activated protein C
8. Factor V and protein S as synergistic cofactors to activated protein C in degradation of factor VIIIa
9. Comparison of activated protein C/protein S-mediated inactivation of human factor VIII and factor V
10. Binding of protein S to factor Va associated with inhibition of prothrombinase that is independent of activated protein C
11. Human protein S inhibits prothrombinase complex activity on endothelial cells and platelets via direct interactions with factors Va and Xa
12. Inhibition of the intrinsic factor X activating complex by protein S: Evidence for a specific binding of protein S to factor VIII
13. A plasma coagulation assay for an activated protein C-dependent anticoagulant activity of protein S
14. Isolation and sequence of the cDNA for human protein S, a regulator of blood coagulation
15. Cloning and characterization of human liver cDNA encoding a protein S precursor
16. SHBG region of the anticoagulant cofactor protein S: Secondary structure prediction, circular dichroism spectroscopy, and analysis of naturally occurring mutations
17. Characterization of functionally important domains in human vitamin K-dependent protein S using monoclonal antibodies
18. Expression and functional characterization of chimeras between human and bovine vitamin-K-dependent protein-S-defining modules important for the species specificity of the activated protein C cofactor activity
19. Characterization of recombinant epidermal growth factor (EGF)-like modules from vitamin-K-dependent protein S expressed in Spodoptera cells
20. Amino acid residues in thrombin-sensitive region and first epidermal growth factor domain of vitamin K-dependent protein S determining specificity of the activated protein C cofactor function
21. The SHBG-like region of protein S is crucial for factor V-dependent APC-cofactor function
22. Characterization of mini-protein S, a recombinant variant of protein S that lacks the sex hormone binding globulin-like domain
23. Binding site for C4b-binding protein in vitamin K-dependent protein S fully contained in carboxy-terminal laminin-G-type repeats. A study using recombinant factor IX-protein S chimeras and surface plasmon resonance
24. Inhibition of protein Ca cofactor function of human and bovine protein S by C4b-binding protein
25. Resistance to activated protein C in nine thrombophilic families: Interference in a protein S functional assay
26. Protein S deficiency: A database of mutations. For the Plasma Coagulation Inhibitors Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis
27. Protein S deficiency: Different biological phenotypes according to the assays used
28. Identification of 15 different candidate causal point mutations and three polymorphisms in 19 patients with protein S deficiency using a scanning method for the analysis of the protein S active gene
29. Identification of 19 protein S gene mutations in patients with phenotypic protein S deficiency and thrombosis. Protein S Study Group
30. Protein S Tokushima: Abnormal molecule with a substitution of Glu for Lys-155 in the second epidermal growth factor-like domain of protein S
31. A mutation of the active protein S gene leading to an EGF1-lacking protein in a family with qualitative (type II) deficiency
32. Protein S Tokushima: An abnormal protein S found in a Japanese family with thrombosis
33. Molecular mechanism of the dysfunction of protein S (Tokushima) (Lys155 → Glu) for the regulation of the blood coagulation system
34. A phenotypically neutral dimorphism of protein S: The substitution of Lys 155 by Glu in the second EGF domain predicted by an A to G base exchange in the gene
35. Binding of bovine coagulation factor Xa to platelets
36. Purification of human C4b-binding protein and formation of its complex with vitamin K-dependent protein S
37. Inactivation of human coagulation factor V by activated protein C
38. In vitro characterisation of two naturally occurring muations in the thrombin-sensitive region of anticoagulant proteins S
39. A new direct, fast and quantitative enzyme-linked ligandsorbent assay for measurement of free protein S antigen
40. Cleavage requirements for activation of factor V by factor Xa
41. New insights into how blood clots: Implications for the use of APTT and PT as coagulation screening tests and in monitoring of anticoagulant therapy
42. A theoretical model for the Gla-TSR-EGF-1 region og the anticoagulant cofactor protein S: From biostructural pathology to species-specific cofactor activity